BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, July 25, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
Orantinib advances through studies in NSCLC and breast cancer
Oct. 19, 2011
Halozyme discloses clinical results on new Herceptin formulation
Oct. 19, 2011
Trial determines phase II doses of ixabepilone/cisplatin combination regimen in NSCLC
Oct. 19, 2011
Interim first-in-human data released on two c-Met inhibitors
Oct. 19, 2011
AB Science recruits first patient in phase III masitinib trial
Oct. 18, 2011
Infinity Pharmaceuticals provides update on IPI-926 trials
Oct. 18, 2011
Novel autotaxin inhibitors designed by Merck KGaA
Oct. 18, 2011
ABI-007 advances through trial in gastric cancer
Oct. 18, 2011
First-in-patient study assesses EMD-525797 in metastatic CRPC
Oct. 18, 2011
Results made available from MENZA trial of enzastaurin
Oct. 18, 2011
Previous
1
2
…
2497
2498
2499
2500
2501
2502
2503
2504
2505
…
4157
4158
Next
RSS